Physician profile
Brandon S Lu
NPI 1093836710
$1,822.34
in general payments reported to CMS, 2019-2025
26 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2021: $179 · 2022: $309 · 2023: $250 · 2024: $386 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.35 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $386.14 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Jazz Pharmaceuticals INC. | $210.70 | 2019-2024 | |
| Glaxosmithkline, LLC. | $154.45 | 2019-2023 | Trelegy Ellipta |
| Stryker Corporation | $127.88 | 2025 | Flowtriever |
| Astrazeneca Pharmaceuticals LP | $126.74 | 2019-2024 | Breztri, Airsupra |
| Grifols USA, LLC | $100.47 | 2019-2021 | |
| Resmed Corp | $91.93 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.69 | 2021-2023 | Ofev |
| Harmony Biosciences LLC | $67.68 | 2023 | Wakix |
| Lilly USA, LLC | $62.62 | 2025 | Zepbound |
| Avadel Cns Pharmaceuticals, LLC | $54.76 | 2024 | Lumryz |
| Coaptech, INC. | $40.10 | 2023 | Puma System |
| Teva Pharmaceuticals USA, INC. | $38.13 | 2019 | |
| Verona Pharma, INC. | $34.69 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $31.04 | 2023 | Sunosi |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $30.04 | 2024 | |
| United Therapeutics Corporation | $25.16 | 2019 | |
| Genentech USA, INC. | $21.38 | 2021 | |
| Advanced Respiratory, INC | $20.50 | 2021 | |
| Genzyme Corporation | $18.92 | 2021 | |
| Merck Sharp & Dohme LLC | $18.00 | 2019 | |
| Portola Pharmaceuticals, LLC | $17.70 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.99 | 2019 | |
| Mylan Specialty L.P. | $14.24 | 2021 | |
| Circassia INC. | $13.64 | 2019 | |
| Electromed, INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.